TriSalus Life Sciences, Inc. (TLSI)
5.07
-0.07
(-1.36%)
USD |
NASDAQ |
Sep 03, 10:01
TriSalus Life Sciences Price to Book Value : 47.58 for Sept. 3, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 48.24 |
| September 01, 2026 | 48.52 |
| August 31, 2026 | 46.45 |
| August 28, 2026 | 45.33 |
| August 27, 2026 | 46.26 |
| August 26, 2026 | 46.26 |
| August 25, 2026 | 47.20 |
| August 24, 2026 | 47.95 |
| August 21, 2026 | 49.46 |
| August 20, 2026 | 49.08 |
| August 19, 2026 | 51.52 |
| August 18, 2026 | 50.68 |
| August 17, 2026 | 49.46 |
| August 14, 2026 | 49.46 |
| August 13, 2026 | 52.83 |
| August 12, 2026 | 53.58 |
| August 11, 2026 | 53.87 |
| August 10, 2026 | 52.36 |
| August 07, 2026 | 52.65 |
| August 06, 2026 | 45.70 |
| August 05, 2026 | 43.36 |
| August 04, 2026 | 44.48 |
| August 03, 2026 | 44.58 |
| July 31, 2026 | 42.61 |
| July 30, 2026 | 42.79 |
| Date | Value |
|---|---|
| July 29, 2026 | 41.10 |
| July 28, 2026 | 40.63 |
| July 27, 2026 | 40.54 |
| July 24, 2026 | 39.60 |
| July 23, 2026 | 40.07 |
| July 22, 2026 | 39.79 |
| July 21, 2026 | 40.73 |
| July 20, 2026 | 40.45 |
| July 17, 2026 | 40.26 |
| July 16, 2026 | 40.92 |
| July 15, 2026 | 38.48 |
| July 14, 2026 | 37.91 |
| July 13, 2026 | 39.70 |
| July 10, 2026 | 38.85 |
| July 09, 2026 | 36.51 |
| July 08, 2026 | 34.53 |
| July 07, 2026 | 38.19 |
| July 06, 2026 | 40.45 |
| July 02, 2026 | 44.01 |
| July 01, 2026 | 41.85 |
| June 30, 2026 | 42.70 |
| June 29, 2026 | 22.73 |
| June 26, 2026 | 22.68 |
| June 25, 2026 | 20.96 |
| June 24, 2026 | 19.95 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.801 |
| Alnylam Pharmaceuticals, Inc. | 26.24 |
| Anika Therapeutics, Inc. | 2.073 |
| Savara, Inc. | 7.664 |
| Vericel Corp. | 5.607 |
Price to Book Value Related Metrics
| PS Ratio | 5.638 |
| PEG Ratio | -0.3953 |
| Price | 5.07 |
| Earnings Yield | -25.54% |
| Market Cap | 311.65M |
| PEGY Ratio | -0.3953 |